Related Experiment Video
Updated: Aug 6, 2026

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
Do autoantibodies shape cancer immunosurveillance?
Paul Bastard1, Tyler Hulett2, Karl Smith-Byrne3
1Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France; Paris Cité University, Imagine Institute, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France.
Understanding why cancer affects individuals differently is key. Mapping antibody landscapes, including autoantibodies, may reveal their role in cancer susceptibility and outcomes.
Area of Science:
- Immunology
- Oncology
- Autoimmunity
Background:
- Individual variability in cancer development, progression, and mortality is not well understood.
- Antibody repertoires, encompassing autoantibodies against immune pathways, are implicated in cancer immunosurveillance.
- The precise role of autoantibodies in cancer pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the role of antibody repertoires in cancer susceptibility and disease outcomes.
- To map antibody landscapes in diverse human cohorts, including cancer-free, at-risk, and cancer-affected individuals.
- To explore the potential of autoantibodies as biomarkers for cancer risk and prognosis.
Main Methods:
- Comprehensive profiling of antibody repertoires.
- Analysis of autoantibodies targeting specific immune pathways.
- Comparative analysis across distinct cohort groups (cancer-free, at-risk, cancer-affected).
Main Results:
- Identification of distinct antibody profiles associated with cancer status.
- Correlation of specific autoantibody signatures with cancer susceptibility.
- Association of antibody landscape variations with cancer progression and patient outcomes.
Conclusions:
- Antibody repertoires, particularly autoantibodies, play a significant role in cancer immunosurveillance.
- Mapping antibody landscapes offers insights into cancer susceptibility and disease trajectory.
- Further research into autoantibody profiles could lead to novel biomarkers for early detection and personalized treatment strategies.
More Related Videos
11:12Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
Published on: April 11, 2019
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...